Dikla Czaczkes Akselbrad is the Executive Vice President and Chief Financial Officer of PolyPid, a global clinical-stage biopharmaceutical company focused on developing, manufacturing, and commercializing novel, locally administered therapies to improve surgical outcomes. Before joining PolyPid seven years ago, she served as CFO at both Compugen and Packet Technologies and as Audit Manager at Ernst & Young Israel. She holds an MBA in Finance and a BA in Accounting & Economics, both from Tel Aviv University, and is a certified public accountant in Israel.